Caprock Group’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $313K | Hold |
3,853
| – | – | 0.01% | 855 |
|
|
2024
Q4 | $347K | Hold |
3,853
| – | – | 0.01% | 748 |
|
|
2024
Q3 | $381K | Sell |
3,853
-1
| -0% | -$99 | 0.01% | 645 |
|
|
2024
Q2 | $357K | Sell |
3,854
-597
| -13% | -$55.4K | 0.01% | 635 |
|
|
2024
Q1 | $422K | Hold |
4,451
| – | – | 0.02% | 461 |
|
|
2023
Q4 | $398K | Sell |
4,451
-1,340
| -23% | -$120K | 0.03% | 459 |
|
|
2023
Q3 | $423K | Sell |
5,791
-3,052
| -35% | -$223K | 0.03% | 399 |
|
|
2023
Q2 | $736K | Buy |
8,843
+1,155
| +15% | +$96.1K | 0.05% | 274 |
|
|
2023
Q1 | $586K | Buy |
7,688
+62
| +0.8% | +$4.73K | 0.05% | 325 |
|
|
2022
Q4 | $633K | Buy |
7,626
+660
| +9% | +$54.8K | 0.06% | 241 |
|
|
2022
Q3 | $553K | Buy |
6,966
+476
| +7% | +$37.8K | 0.05% | 258 |
|
|
2022
Q2 | $482K | Buy |
+6,490
| New | +$482K | 0.05% | 273 |
|